STK11/LKB1 Mutation-positive Primary Thymic Mucinous Adenocarcinoma Accompanied by Cerebellar Metastasis: A Case Report and Literature Review.

[1]  C. Moran,et al.  Primary thymic adenocarcinomas: a clinicopathological and immunohistochemical study of 16 cases with emphasis on the morphological spectrum of differentiation. , 2018, Human pathology.

[2]  Y. Maehara,et al.  Mucinous adenocarcinoma of the thymus: report of a case , 2018, General Thoracic and Cardiovascular Surgery.

[3]  Yin Yin,et al.  Primary Mucinous Adenocarcinoma of the Thymus: A Case Report and Literature Review. , 2017, Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih.

[4]  D. Fujimoto,et al.  KRAS mutation-positive mucinous adenocarcinoma originating in the thymus. , 2017, Journal of thoracic disease.

[5]  M. Mitsuoka,et al.  Mucinous cystic tumor with CK20 and CDX2 expression of the thymus: Is this a benign counterpart of adenocarcinoma of the thymus, enteric type? , 2016, Pathology international.

[6]  A. Marx,et al.  Adenocarcinoma of the Thymus, Enteric Type: Report of 2 Cases, and Proposal for a Novel Subtype of Thymic Carcinoma , 2015, The American journal of surgical pathology.

[7]  C. Moran,et al.  Thymic carcinoma, part 1: a clinicopathologic and immunohistochemical study of 65 cases. , 2012, American journal of clinical pathology.

[8]  M. Fukayama,et al.  Mucinous adenocarcinoma of the thymus: a distinct variant of thymic carcinoma. , 2009, Lung cancer.

[9]  M. Stratton,et al.  LKB1/KRAS mutant lung cancers constitute a genetic subset of NSCLC with increased sensitivity to MAPK and mTOR signalling inhibition , 2009, British Journal of Cancer.

[10]  M. Kojima,et al.  Mucinous adenocarcinoma of the thymus: a case report. , 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[11]  R. Cameron,et al.  Mucinous Adenocarcinomas of the Thymus: Report of 2 Cases and Review of the Literature , 2007, The American journal of surgical pathology.

[12]  Y. Matsuno,et al.  Adenocarcinoma of the thymus: mucinous subtype. , 2005, Human pathology.

[13]  R. DePinho,et al.  Regulation of the TSC pathway by LKB1: evidence of a molecular link between tuberous sclerosis complex and Peutz-Jeghers syndrome. , 2004, Genes & development.

[14]  Jérôme Boudeau,et al.  LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR‐1 , 2004, The EMBO journal.

[15]  E. Hafen,et al.  Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2. , 2003, Molecular cell.

[16]  W. Choi,et al.  Adenocarcinoma of the Thymus: Report of Two Cases, Including a Previously Undescribed Mucinous Subtype , 2003, The American journal of surgical pathology.

[17]  J. Rosai,et al.  CD5 labeling of thymic carcinomas and other nonlymphoid neoplasms. , 1998, American journal of clinical pathology.

[18]  M. Fukayama,et al.  CD5 expression in thymic carcinoma. , 1994, The American journal of pathology.

[19]  Makoto Ito,et al.  Primary mucinous adenocarcinoma of the thymus: a case report , 2014 .